Results

Total Results: 2,208 records

Showing results for "drug".

361. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
     May 07, 2010 - List of angiotensin converting enzyme inhibitors (ACEIs), with the U.S.Food and Drug Administration … X versus an ARB + drug X (e.g., losartan + hydrochlorothiazide [HCTZ] versus enalapril + HCTZ) … • We will exclude comparisons of an ACEI + drug X versus an ARB + drug Y (e.g., enalapril + manidipine … “ACE inhibitors” or unspecified “ARBs” vs. unspecified “ACEIs” - Include ACEI + drug X vs. … ARB + drug X (e.g., losartan + HCTZ vs. enalapril + HCTZ) - Exclude ACEI + drug X vs.

362. Communicating Harms and Benefits of Prescription Drugs to Health Care Consumers | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/eccs-2006/white-paper
     November 01, 2017 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

363. Evidence-based Practice Center Systematic Review Protocol: Depression in Children: Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/depression-childhood-protocol.pdf
     August 06, 2018 - Reaction Reporting Systems"] or [mh Accidents] or accident*:ti,ab or [mh "Drug Toxicity"] or [mh "Drug … Allergies" OR DE "Drug Dependency" OR TX “drug effects” OR DE "Drug Sensitivity" OR TX harm* OR TX … Reaction Reporting Systems” OR Accidents OR accident* OR “Drug Toxicity” OR “Drug Hypersensitivity … Allergies" OR DE "Drug Dependency" OR TX “drug effects” OR DE "Drug Sensitivity" OR TX harm* OR TX … Reaction Reporting Systems” OR Accidents OR accident* OR “Drug Toxicity” OR “Drug Hypersensitivity

364. Medical Care Journal Supplement (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/toc.pdf
     January 01, 2007 - Designed Delays Versus Rigorous Pragmatic Trials: Lower Carat Gold Standards Can Produce Relevant Drug … Studying Prescription Drug Use and Outcomes with Medicaid Claims Data: Strengths, Limitations, and … Developing Indicators of Inpatient Adverse Drug Events Through Non-Linear Analysis Using Administrative … Evaluation and Overview of the National Electronic Injury Surveillance System- Cooperative Adverse Drug

365. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - similar drugs in the same class are read separately), and then topics in the same class of a device, drug … Biogen (Cambridge, MA) has advanced this candidate drug to phase III testing, despite initial analysis … to have antiamyloidogenic properties, and oral ibuprofen, a common nonsteroidal anti-inflammatory drug … the widely- used cough suppressant dextromethorphan with quinidine, a class Ia antiarrhythmic drug, … AVP-786’s mechanism of action is unknown, but developers designed the drug using deuterium-modified

366. Antipsychotics-Children Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
     June 04, 2010 - Food and Drug Administration (FDA). … antipsychotic drug. … All formulations of drug delivery (e.g., tablet, liquid, injectable) and doses are eligible. … dose of the same antipsychotic drug. … National Library of Medicine’s TOXLINE® and MedEffectTM Canada Adverse Drug Reaction Database.

367. Disposition of Comments for CER 208 Treatment for Bipolar Disorder in Adults A Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-adults-disposition-comments.pdf
     August 07, 2018 - The Benefits do NOT, in ANY WAY, outweight the risks of this drug. … This drug is a health hazard. My husband is somehow still living proof of this. … Get this drug OFF of the market, thank you all very MUCH for NOTHING but MISERY. … His walking and cognitive skills are richly impaired...thanks to this drug. … regard for safety of drug efficacy, which was NEGATIVE int the extreme!!!!!!

368. S3 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/s3.pdf
     October 01, 2007 - about the occurrence and outcomes of conditions that were being targeted by therapies in the Merck drug … Beyond pharmacoepide- miology: the larger role of epidemiology in drug development. … Exposure-time-varying hazard function ratios in case-control studies of drug effects. … Pharmacoepidemiol Drug Saf. 2006;15:81–92.

369. Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/antidepressants-update/research
     December 01, 2019 - White Paper Jan 07, 2025 Enhancing Systematic Review Methods by Incorporating Unpublished Drug

370. Fibromyalgia Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/fibromyalgia_executive.pdf
     January 01, 2015 - Twenty studies were drug trials (59%). … All eight pooled analyses of patient-level RCT data were drug studies. … Corresponding and other authors in drug trials were often industry employees. … Most drug trials were placebo-controlled RCTs. … Reporting issues were particularly prominent in drug studies.

371. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1512.pdf
     December 29, 2015 - High treatment costs could limit patient access if third-party payers do not cover the drug. … High cost could limit patient access to the drug. … Some experts thought that as a new drug, lesinurad would be more expensive than existing options. … drug- name=tofacitinib. 69. Mayo Clinic staff. Rheumatoid arthritis. [internet]. … drug-name=tofacitinib http://www.goodrx.com/tofacitinib?

372. Evidence Report on the (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotics-adults_research-protocol.pdf
     December 01, 2010 - recommends that selection of an antipsychotic should be based on a patient’s previous responses to the drug … Study inclusion in the CER will not be limited by drug dosage. 4. … Food and Drug Administration (FDA). Comparators: Any commercially available FDA-approved SGA. … All methods of drug delivery (e.g., tablet, liquid, injection) will be eligible. … (neuroleptic adj2 (agent* or drug*)).tw. 28. or/25-27 29.

373. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
     January 01, 2012 - In 2001, teduglutide received orphan drug designation for treatment of SBS. … In August 2011, NPS began submitting data for a new drug application to FDA for the same indication … Additional, less salient considerations included potential drug-drug interactions, the possibility … The drug is also expected to be widely accepted by patients. … Food and Drug Administration (FDA); 2009 Oct 2 [accessed 2011 Feb 14]. [2 p].

374. Sleep Disorders | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/sleep-disorders
     January 16, 2024 - sleepdisorders.html Products Rapid Evidence Product January 16, 2024 Reducing Adverse Drug … September 29, 2023 Making Healthcare Safer IV: Protocols for High-Risk Drugs: Reducing Adverse Drug

375. DEcIDE 33: Summary Variables in Observational Resesarch: Propensity Scores and Disease Risk Scores (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
     May 01, 2012 - If a patient has high cholesterol and is on other medications, then the potential for drug-drug interactions … For example, perhaps an adverse effect of a drug is only apparent when the drug is prescribed to people … Pharmacoepidemiol Drug Saf 2005;14:S22- 3. 16. … Pharmacoepidemiol Drug Safety 2005;14(7):465-76. … Pharmacoepidemiol Drug Saf 2005;14:S21.

376. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
     September 01, 2011 - Food and Drug Administration (FDA) recently placed a box warning on the entire class of biologic DMARDs … Health Assessment Questionnaire; CI = confidence interval; DMARD(s) = disease-modifying anti-rheumatic drug

377. Effective Health Care (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0316_03-12-2009.pdf
     January 01, 2009 - It can also be used to adjust anti-hypertensive drug therapy and reduce clinic visits with patients. … Use of anti-hypertensive drug therapy iv. BP control 3. … Use of anti-hypertensive drug therapy iv. BP control 4.

378. does use of generic medications for seizures result in poorer control (more ER visits and or hospitalizations than the use of brand name medications. | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/does-use-of-generic-medications-for-seizures-result-in-poorer-control-more-er-visits-and-or-hospitalizations-than-the-use-of-brand-name-medications
     November 01, 2017 - Appropriateness for EHC Program Does your question include a health care drug, intervention, device … interest in drug related topics.

379. Appendix A: Management of Suicidal Thoughts and Behaviors in Youth (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-appendix-a.pdf
     September 26, 2023 - ).ti,ab,kf. 5 1 or 2 or 3 or 4 6 Therapeutics/ 7 (dm or dt or th).fs. 8 exp Psychotherapy/ 9 Drug … therap*" or "dialectical behavioural therap*" or Digital or dimethyltryptamine or DMT or doximity or drug … therap*" OR "dialectical behavioural therap*" OR Digital OR dimethyltryptamine OR DMT OR doximity OR drug

380. Treatments for Seasonal Allergic Rhinitis | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/allergy-seasonal/research
     December 01, 2019 - Food and Drug Administration (FDA).